BRAIN VOLUME CHANGE AND DISABILITY IN FINGOLIMOD TRIALS (2014), Nicholas Richard | AcademicGPT, tlooto

BV loss was greatest in patients who relapsed or who developed new Gd+ or T2-lesions and by reducing BV loss, fingolimod may slow disability progression. (2014), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Nicholas Richard | AcademicGPT, tlooto for Academic and Research